Akebia Therapeutics (NASDAQ:AKBA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Akebia Therapeutics missed estimated earnings by 21.21%, reporting an EPS of $-0.4 versus an estimate of $-0.33.
Revenue was up $2.91 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 3.62% drop in the share price the next day.
Here’s a look at Akebia Therapeutics’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.32 | -0.36 | -0.4 |
| EPS Actual | -0.34 | -0.51 | -0.45 | -0.6 |
| Revenue Estimate | 49.67M | 52.88M | 42.84M | 51.16M |
| Revenue Actual | 48.76M | 52.91M | 52.30M | 56.70M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
